Toshiyuki Mori

CEO, TM Partners LLC
Summary
Dr. Toshiyuki Mori is a highly accomplished professional with an extensive background in the pharmaceutical industry.
He holds a PhD in Pharmaceutical and has studied at Hokkaido University, showcasing his strong academic foundation.
With vast experience in various organizations, Dr. Mori has served in key roles such as Independent Board Director at EditForce, Inc., offering valuable insights and guidance.
His previous roles include serving as an Independent Board Director at J-Pharma Co., Ltd., Deputy Director at Toyama Pharmaceutical Valley Development Consortium, and Chief Executive Officer at TM Partners LLC.
Dr. Mori's expertise extends to the investment sector, having been an Investment Partner at Newton Biocapital SA.
Moreover, he has held important positions at renowned companies like Takeda Pharmaceutical Company Ltd., where he served as Director, Sinor Director at Takeda San Francisco, Associate Director at Takeda Pharmaceutical Company, and Staff Scientist at The U.S. National Cancer Institute.
His leadership as Director & CSO at Whiz Partners, Inc. underscores his strategic vision and business acumen.
Throughout his career, Dr. Mori has demonstrated a deep understanding of the pharmaceutical landscape and a commitment to driving innovation and growth within the industry.